FDA Raps Another Catalent Facility for Multiple Lapses
On the heels of a recent FDA write-up, another Catalent facility drew a Form 483 from the agency for multiple quality lapses following an inspection of its Brussels, Belgium, plant.
Source: Drug Industry Daily